In 2021, the Center for Drug Evaluation of the National Medical Products Administration (NMPA) in China received more than 65 New Drug Applications (NDA) for innovative drugs. Most NDA applications were concerning innovative chemical drugs or biopharmaceuticals, with only ten innovative Traditional Chinese Medicine (TCM) NDA applications submitted in 2021. A New Drug Application (NDA) is the mechanism through which pharmaceutical manufacturers propose that the regulatory body approve a new drug or biopharmaceutical for general use and sale.
Number of New Drug Applications (NDA) for innovative drugs submitted in China from 2018 to 2021, by drug type
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
National Medical Products Administration. (June 1, 2022). Number of New Drug Applications (NDA) for innovative drugs submitted in China from 2018 to 2021, by drug type [Graph]. In Statista. Retrieved December 23, 2024, from https://www.statista.com/statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration. "Number of New Drug Applications (NDA) for innovative drugs submitted in China from 2018 to 2021, by drug type." Chart. June 1, 2022. Statista. Accessed December 23, 2024. https://www.statista.com/statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration. (2022). Number of New Drug Applications (NDA) for innovative drugs submitted in China from 2018 to 2021, by drug type. Statista. Statista Inc.. Accessed: December 23, 2024. https://www.statista.com/statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration. "Number of New Drug Applications (Nda) for Innovative Drugs Submitted in China from 2018 to 2021, by Drug Type." Statista, Statista Inc., 1 Jun 2022, https://www.statista.com/statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration, Number of New Drug Applications (NDA) for innovative drugs submitted in China from 2018 to 2021, by drug type Statista, https://www.statista.com/statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/ (last visited December 23, 2024)
Number of New Drug Applications (NDA) for innovative drugs submitted in China from 2018 to 2021, by drug type [Graph], National Medical Products Administration, June 1, 2022. [Online]. Available: https://www.statista.com/statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/
